- Home
- GPRO vs CINGW Comparison
GPRO vs CINGW Comparison
Compare GPRO & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRO
- CINGW
- Stock Information
- Founded
- GPRO 2004
- CINGW N/A
- Country
- GPRO United States
- CINGW United States
- Employees
- GPRO N/A
- CINGW 13
- Industry
- GPRO Industrial Machinery/Components
- CINGW Biotechnology: Pharmaceutical Preparations
- Sector
- GPRO Consumer Discretionary
- CINGW Health Care
- Exchange
- GPRO Nasdaq
- CINGW Nasdaq
- Market Cap
- GPRO 193.5M
- CINGW N/A
- IPO Year
- GPRO 2014
- CINGW 2021
- Fundamental
- Price
- GPRO $1.10
- CINGW $0.04
- Analyst Decision
- GPRO Hold
- CINGW
- Analyst Count
- GPRO 1
- CINGW 0
- Target Price
- GPRO $1.50
- CINGW N/A
- AVG Volume (30 Days)
- GPRO 1.7M
- CINGW N/A
- Earning Date
- GPRO 02-05-2025
- CINGW N/A
- Dividend Yield
- GPRO N/A
- CINGW N/A
- EPS Growth
- GPRO N/A
- CINGW N/A
- EPS
- GPRO N/A
- CINGW N/A
- Revenue
- GPRO $896,011,000.00
- CINGW N/A
- Revenue This Year
- GPRO N/A
- CINGW N/A
- Revenue Next Year
- GPRO N/A
- CINGW N/A
- P/E Ratio
- GPRO N/A
- CINGW N/A
- Revenue Growth
- GPRO N/A
- CINGW N/A
- 52 Week Low
- GPRO $1.08
- CINGW N/A
- 52 Week High
- GPRO $3.58
- CINGW N/A
- Technical
- Relative Strength Index (RSI)
- GPRO 37.45
- CINGW N/A
- Support Level
- GPRO $1.21
- CINGW N/A
- Resistance Level
- GPRO $1.36
- CINGW N/A
- Average True Range (ATR)
- GPRO 0.06
- CINGW 0.00
- MACD
- GPRO -0.01
- CINGW 0.00
- Stochastic Oscillator
- GPRO 9.71
- CINGW 0.00
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
About CINGW Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.